|
US2444570A
(en)
|
|
1948-07-06 |
|
Drive for counter numeral wheels |
|
GB735443A
(en)
|
1952-09-02 |
1955-08-24 |
English Numbering Machines |
Improvements in or relating to counting devices
|
|
US2828742A
(en)
|
1957-05-02 |
1958-04-01 |
American Home Prod |
Cartridge-needle unit
|
|
BE639963A
(sr)
|
1963-05-02 |
|
|
|
|
US3318289A
(en)
|
1965-05-11 |
1967-05-09 |
Northern Ind Products |
Bi-stable mechanism
|
|
CH499734A
(de)
|
1968-07-19 |
1970-11-30 |
Kienzle Apparate Gmbh |
Klinkengesperre als Einrichtungs- und Überholkupplung
|
|
US3758683A
(en)
|
1971-04-30 |
1973-09-11 |
R Jackson |
Insulin product
|
|
US4282316A
(en)
|
1979-09-11 |
1981-08-04 |
Modrovich Ivan Endre |
Stabilized enzymic solutions for determining urea
|
|
GB2072015B
(en)
|
1980-03-21 |
1983-12-21 |
Wellcome Found |
Compositions containing polymyxin
|
|
US4425346A
(en)
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
|
GB2109690B
(en)
|
1981-02-12 |
1985-02-20 |
Robert Charles Turner |
Dose metering plunger devices for use with syringes
|
|
US4568335A
(en)
|
1981-08-28 |
1986-02-04 |
Markwell Medical Institute, Inc. |
Device for the controlled infusion of medications
|
|
DE3204178C2
(de)
|
1982-02-06 |
1986-03-20 |
Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg |
Pipettiervorrichtung
|
|
US4483849A
(en)
|
1983-01-07 |
1984-11-20 |
Carter William A |
Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
|
|
GB2141799B
(en)
|
1983-06-03 |
1986-07-16 |
Diehl Gmbh & Co |
An adjusting ratchet mechanism for a time switch
|
|
DE3468173D1
(en)
|
1983-09-07 |
1988-02-04 |
Disetronic Ag |
Portable infusion apparatus
|
|
US4468346A
(en)
|
1983-10-27 |
1984-08-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies to porcine immunoglobulins
|
|
JPS60129941U
(ja)
|
1984-02-09 |
1985-08-31 |
テルモ株式会社 |
医療用器具
|
|
US4592745A
(en)
|
1984-02-29 |
1986-06-03 |
Novo Industri A/S |
Dispenser
|
|
FR2583291A1
(fr)
|
1985-06-14 |
1986-12-19 |
Hazon Bernard |
Dispositif d'avancement pas a pas du piston de seringues par double vis coaxiale avec controle du debit d'injection. application aux injections medicamenteuses intra-dermiques repetitives
|
|
DE3546150A1
(de)
|
1985-06-24 |
1987-01-22 |
Hoechst Ag |
Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
|
|
DE3670768D1
(de)
|
1985-11-08 |
1990-06-07 |
Disetronic Ag |
Injektionsgeraet.
|
|
DE3609555A1
(de)
|
1986-03-21 |
1987-09-24 |
Josef Porner |
Blutentnahmespritze
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
EP1498425A1
(en)
|
1986-05-05 |
2005-01-19 |
The General Hospital Corporation |
Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US4917685A
(en)
|
1986-05-16 |
1990-04-17 |
International Minerals & Chem. Corp. |
Delivery device for the administration of stabilized growth promoting hormones
|
|
DE3645245C2
(de)
|
1986-11-14 |
1994-01-27 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
|
US5716990A
(en)
|
1987-03-09 |
1998-02-10 |
Cancer Research Campaign Technology Limited |
Drug delivery systems
|
|
DK177187A
(da)
|
1987-04-07 |
1988-10-08 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glasampul
|
|
DE3715258C2
(de)
|
1987-05-08 |
1996-10-31 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
|
AU616411B2
(en)
|
1987-05-14 |
1991-10-31 |
Commonwealth Scientific And Industrial Research Organisation |
Whey protein fractions
|
|
GB8713810D0
(en)
|
1987-06-12 |
1987-07-15 |
Hypoguard Uk Ltd |
Measured dose dispensing device
|
|
FI883338A
(fi)
|
1987-07-16 |
1989-01-17 |
Bristol Myers Co |
Vattenloesningar av doxorubicinhydroklorid.
|
|
IT1222331B
(it)
|
1987-08-25 |
1990-09-05 |
Bruno Micovilovich |
Siringa di sicurezza per usi parentali,a disimpegno autonomo e rapido dell'ago dopo l'uso
|
|
US4919596A
(en)
|
1987-12-04 |
1990-04-24 |
Pacesetter Infusion, Ltd. |
Fluid delivery control and monitoring apparatus for a medication infusion system
|
|
US4833379A
(en)
|
1988-01-13 |
1989-05-23 |
Sherwood Medical Company |
Motor control fail-safe circuit
|
|
CH675078A5
(sr)
|
1988-01-22 |
1990-08-31 |
Nosta Ag |
|
|
DE3900926C2
(de)
|
1988-02-08 |
1999-05-12 |
Disetronic Licensing Ag |
Spritzenförmiges Injektionsgerät und Injektionsgerätebaukasten
|
|
DK166948B1
(da)
|
1988-02-10 |
1993-08-09 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glastubule
|
|
US4973318A
(en)
|
1988-02-10 |
1990-11-27 |
D.C.P. Af 1988 A/S |
Disposable syringe
|
|
WO1990000200A1
(en)
|
1988-06-27 |
1990-01-11 |
Genex Corporation |
Thermal release of recombinant protein into culture media
|
|
DE58908873D1
(de)
|
1988-09-12 |
1995-02-23 |
Graesslin Kg |
Richtgesperre für eine Schaltuhr.
|
|
GB8900763D0
(en)
|
1989-01-13 |
1989-03-08 |
Kabi Vitrum Peptide Hormones A |
Multi-dose syringe
|
|
US5216437A
(en)
|
1989-02-02 |
1993-06-01 |
Canon Kabushiki Kaisha |
Ink, and recording method making use of same
|
|
DK68789A
(da)
|
1989-02-14 |
1990-08-15 |
Novo Nordisk As |
Injektionspen
|
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
|
DE68929217T2
(de)
|
1989-03-20 |
2000-11-30 |
The General Hospital Corp., Boston |
Insulinotropes hormon
|
|
JP2822447B2
(ja)
|
1989-05-19 |
1998-11-11 |
住友電気工業株式会社 |
酸化物超電導線材の製造方法および装置
|
|
US4994033A
(en)
|
1989-05-25 |
1991-02-19 |
Schneider (Usa) Inc. |
Intravascular drug delivery dilatation catheter
|
|
US5226895A
(en)
|
1989-06-05 |
1993-07-13 |
Eli Lilly And Company |
Multiple dose injection pen
|
|
DE3927286C2
(de)
|
1989-08-18 |
1997-07-24 |
Roehm Gmbh |
Wäßrige Enzym-Flüssigformulierungen
|
|
US5216011A
(en)
|
1989-09-01 |
1993-06-01 |
Bristol-Myers Squibb Co. |
Stable solutions of mitomycin c
|
|
DE69013471T2
(de)
|
1989-12-05 |
1995-03-30 |
Merck & Co Inc |
Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
|
|
DK17890A
(da)
|
1990-01-22 |
1991-07-23 |
Novo Nordisk As |
Fremgangsmaade og apparat til opblanding og injicering af et laegemiddel
|
|
ES2113879T3
(es)
|
1990-01-24 |
1998-05-16 |
Douglas I Buckley |
Analogos de glp-1 utiles para el tratamiento de diabetes.
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
DE4002066A1
(de)
|
1990-01-25 |
1991-08-01 |
Basf Ag |
Verfahren zur abtrennung von riboflavin aus fermentationssuspensionen
|
|
GB9007113D0
(en)
|
1990-03-29 |
1990-05-30 |
Sams Bernard |
Dispensing device
|
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
|
US5318540A
(en)
|
1990-04-02 |
1994-06-07 |
Pharmetrix Corporation |
Controlled release infusion device
|
|
US5492534A
(en)
|
1990-04-02 |
1996-02-20 |
Pharmetrix Corporation |
Controlled release portable pump
|
|
US5226896A
(en)
|
1990-04-04 |
1993-07-13 |
Eli Lilly And Company |
Dose indicating injection pen
|
|
IT220491Z2
(it)
|
1990-04-13 |
1993-09-24 |
Stilolinea Srl |
Penna a sfera del tipo a punta scrivente rientrante
|
|
EP0532546B1
(en)
|
1990-05-10 |
1998-03-18 |
Bechgaard International Research And Development A/S |
A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
|
|
US5257987A
(en)
|
1990-05-21 |
1993-11-02 |
Pharmetrix Corporation |
Controlled release osmotic infusion system
|
|
JP3042710B2
(ja)
|
1990-09-21 |
2000-05-22 |
ノボ ノルディスク アクティーゼルスカブ |
ペンシリンジアセンブリー
|
|
US5284480A
(en)
|
1990-11-09 |
1994-02-08 |
Medtronic, Inc. |
Inflation/deflation syringe with threaded plunger
|
|
GB9026191D0
(en)
|
1990-12-01 |
1991-01-16 |
Harris Pharma Ltd |
Breath actuated dispensing device
|
|
US5331954A
(en)
|
1990-12-21 |
1994-07-26 |
Novo Nordisk A/S |
Device for nasal delivery of liquid medications
|
|
US5232706A
(en)
|
1990-12-31 |
1993-08-03 |
Esteve Quimica, S.A. |
Oral pharmaceutical preparation containing omeprazol
|
|
AU641206B2
(en)
|
1991-01-22 |
1993-09-16 |
Eli Lilly And Company |
Multiple dose injection pen
|
|
EP0498737B1
(en)
|
1991-02-07 |
1995-07-19 |
Terumo Kabushiki Kaisha |
Dosing means for an injector
|
|
US5272135A
(en)
|
1991-03-01 |
1993-12-21 |
Chiron Ophthalmics, Inc. |
Method for the stabilization of methionine-containing polypeptides
|
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
|
US5571719A
(en)
|
1991-03-27 |
1996-11-05 |
Novo Nordisk A/S |
Catalase, its production and use
|
|
US5258377A
(en)
|
1991-04-08 |
1993-11-02 |
Taiho Pharmaceutical Co., Ltd. |
2-spirocyclopropyl 4-acylcephems
|
|
DE4112259A1
(de)
|
1991-04-15 |
1992-10-22 |
Medico Dev Investment Co |
Injektionsgeraet
|
|
DK68991D0
(da)
|
1991-04-17 |
1991-04-17 |
Novo Nordisk As |
Manifold
|
|
US5645052A
(en)
|
1991-04-26 |
1997-07-08 |
The Boc Group Plc |
Anaesthetic vaporizer with expandable/contractable reservoir for pumping liquid anaesthetic
|
|
SE9101381D0
(sv)
|
1991-05-07 |
1991-05-07 |
Tomas Moks |
Peptide hormone solution
|
|
EP0525525B1
(de)
|
1991-07-24 |
1995-05-03 |
Medico Development Investment Company |
Injektor
|
|
DK175491D0
(da)
|
1991-10-18 |
1991-10-18 |
Novo Nordisk As |
Apparat
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
US5611783A
(en)
|
1991-11-29 |
1997-03-18 |
Novo Nordisk A/S |
Pen-shaped syringe
|
|
DK194291D0
(da)
|
1991-11-29 |
1991-11-29 |
Novo Nordisk As |
Sproejte til automatisk injektion.
|
|
US5246417A
(en)
|
1991-12-11 |
1993-09-21 |
Alza Corporation |
Indicator for iontophoresis system
|
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
|
FR2686460B1
(fr)
|
1992-01-20 |
1994-03-11 |
Labinal Precision Mecanique |
Organe de contact electrique femelle.
|
|
US5279585A
(en)
|
1992-02-04 |
1994-01-18 |
Becton, Dickinson And Company |
Medication delivery pen having improved dose delivery features
|
|
CH682968B5
(fr)
|
1992-02-12 |
1994-06-30 |
Rolex Montres |
Procédé de fabrication d'un joint et joint pour dispositif de commande étanche pour montre obtenu selon ce procédé.
|
|
CH682806A5
(de)
|
1992-02-21 |
1993-11-30 |
Medimpex Ets |
Injektionsgerät.
|
|
DE4208677A1
(de)
|
1992-03-18 |
1993-09-23 |
Injecta Gmbh Steinach |
Injektionsvorrichtung, insbesondere fuer sehgeschaedigte diabetiker
|
|
DK36492D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Praeparat
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
EP0632734B1
(en)
|
1992-03-25 |
1998-06-10 |
Tebro S.A. |
Powder jet dispenser for medicament inhalation therapies
|
|
US5271527A
(en)
|
1992-04-02 |
1993-12-21 |
Habley Medical Technology Corporation |
Reusable pharmaceutical dispenser with full stroke indicator
|
|
US5281198A
(en)
|
1992-05-04 |
1994-01-25 |
Habley Medical Technology Corporation |
Pharmaceutical component-mixing delivery assembly
|
|
WO1993023010A1
(en)
|
1992-05-13 |
1993-11-25 |
Sandoz Ltd. |
Ophthalmic compositions containing a cyclosporin
|
|
JP2575298B2
(ja)
|
1992-06-15 |
1997-01-22 |
フアイザー・インコーポレイテツド |
グルカゴン様ペプチド及びインシュリノトロピン誘導体
|
|
UA26190C2
(uk)
|
1992-07-28 |
1999-07-19 |
Сейфтек Ай Лімітед |
Шприц
|
|
GB9219849D0
(en)
|
1992-09-19 |
1992-10-28 |
Hypoguard Uk Ltd |
Device
|
|
ES2154651T3
(es)
|
1992-10-15 |
2001-04-16 |
Gen Hospital Corp |
Bomba de infusion con biblioteca de medicamentos cargable electronicamente.
|
|
US5545147A
(en)
|
1992-10-20 |
1996-08-13 |
Eli Lilly And Company |
Anti-backup improvement for hypodermic syringes
|
|
US5378233A
(en)
|
1992-11-18 |
1995-01-03 |
Habley Medical Technology Corporation |
Selected dose pharmaceutical dispenser
|
|
US5320609A
(en)
|
1992-12-07 |
1994-06-14 |
Habley Medical Technology Corporation |
Automatic pharmaceutical dispensing syringe
|
|
GB9226423D0
(en)
|
1992-12-18 |
1993-02-10 |
Sams Bernard |
Incrementing mechanisms
|
|
CZ284900B6
(cs)
|
1993-02-19 |
1999-04-14 |
Medicorp Holding S.A. |
Předem naplněná stříkačka pro uložení a vydávání kapalné a sterilní léčebné látky
|
|
US5383865A
(en)
|
1993-03-15 |
1995-01-24 |
Eli Lilly And Company |
Medication dispensing device
|
|
US5584815A
(en)
|
1993-04-02 |
1996-12-17 |
Eli Lilly And Company |
Multi-cartridge medication injection device
|
|
ZA941881B
(en)
|
1993-04-02 |
1995-09-18 |
Lilly Co Eli |
Manifold medication injection apparatus and method
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
SE9301494D0
(sv)
|
1993-04-30 |
1993-04-30 |
Kabi Pharmacia Ab |
A device for dosing liquid preparation
|
|
DK52393D0
(sr)
|
1993-05-05 |
1993-05-05 |
Novo Nordisk As |
|
|
AU7531094A
(en)
|
1993-08-24 |
1995-03-21 |
Novo Nordisk A/S |
Protracted glp-1
|
|
PL178466B1
(pl)
|
1993-09-17 |
2000-05-31 |
Novo Nordisk As |
Pochodna insuliny i kompozycja farmaceutyczna do leczenia cukrzycy
|
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
|
JPH09505290A
(ja)
|
1993-11-19 |
1997-05-27 |
ジー．ディー．サール アンド カンパニー |
Ｎ‐［Ｎ‐［５‐［４‐（アミノイミノメチル）フェニル］‐１‐オキソペンチル］‐Ｌ‐α‐アスパルチル］‐Ｌ‐フェニルアラニンまたはそのエステル並びにそれらの医薬的に許容される塩類の経皮的組成物
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5478316A
(en)
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
|
US5514097A
(en)
|
1994-02-14 |
1996-05-07 |
Genentech, Inc. |
Self administered injection pen apparatus and method
|
|
US5562623A
(en)
|
1994-02-14 |
1996-10-08 |
Univec |
Single-use syringe assembly including spring clip lock and plunger
|
|
AU1847695A
(en)
|
1994-02-22 |
1995-09-04 |
Syntex-Synergen Neuroscience Joint Venture, The |
Pharmaceutical formulations of cntf
|
|
WO1995029996A1
(en)
|
1994-05-03 |
1995-11-09 |
Novo Nordisk A/S |
Alkaline glucose oxidase
|
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
|
US5750140A
(en)
|
1994-05-20 |
1998-05-12 |
Novo Nordisk A/S |
Transdermal delivery of tiagabine
|
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
|
AU1595395A
(en)
|
1994-06-15 |
1996-01-05 |
Interventional Research Technologies, Inc. |
Locking device for syringe or like instrument
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5827232A
(en)
|
1994-06-22 |
1998-10-27 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
|
US5725508A
(en)
|
1994-06-22 |
1998-03-10 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
|
US5440976A
(en)
|
1994-08-23 |
1995-08-15 |
Fred Giuliano |
Adjustable dispensing stirrer for soluble sweeteners
|
|
CA2186869A1
(en)
|
1994-08-24 |
1996-02-29 |
Hideto Yamagata |
Injection apparatus
|
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
|
US5549574A
(en)
|
1994-08-30 |
1996-08-27 |
Eli Lilly And Company |
Cartridge assembly for use in a pen-type medicament injector
|
|
DE69532492T2
(de)
|
1994-08-31 |
2004-12-02 |
Mitsubishi Pharma Corp. |
Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
|
|
CN1157553A
(zh)
|
1994-09-09 |
1997-08-20 |
诺沃挪第克公司 |
清洁、消毒和防护隐形眼镜的方法
|
|
US5549575A
(en)
|
1994-09-13 |
1996-08-27 |
Becton Dickinson And Company |
Cartridge retainer assembly for medication delivery pen
|
|
US5582598A
(en)
|
1994-09-19 |
1996-12-10 |
Becton Dickinson And Company |
Medication delivery pen with variable increment dose scale
|
|
BR9508847A
(pt)
|
1994-09-20 |
1999-11-30 |
Novo Nordisk A S E Slagterisel |
Processo para tratar uma solução aquosa de proteìna e para produzir um gênero alimentìcio à base de carne, mistura de solução de proteìna/hidrolisado tratada com calor, ou hidrolisado lìquido tratado com calor, gênero alimentìcio à base de carne e uso da mistura de solução de proteìna/hidrolisado tratada com calor, ou de hidrolisado lìquido tratado com calor
|
|
ZA958073B
(en)
|
1994-09-28 |
1996-04-23 |
Anthony William Manicom |
Method of and apparatus for administering a drug to a patient
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
JPH10511365A
(ja)
|
1994-12-23 |
1998-11-04 |
ノボ ノルディスク アクティーゼルスカブ |
遅延性ｇｌｐ−１組成物
|
|
DE69637940D1
(de)
|
1995-02-03 |
2009-07-09 |
Novozymes As |
Eine methode zum entwurf von alpha-amylase mutanten mit vorbestimmten eigenschaften
|
|
JP2000510813A
(ja)
|
1995-02-06 |
2000-08-22 |
ジェネテイックス・インスティテュート・インコーポレイテッド |
Ｉｌ−１２用処方
|
|
GB9503969D0
(en)
|
1995-02-28 |
1995-04-19 |
Sams Bernard |
Incrementing mechanism
|
|
CA2213682C
(en)
|
1995-03-07 |
2009-10-06 |
Eli Lilly And Company |
Recyclable medication dispensing device
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
EP0871665B1
(en)
|
1995-03-17 |
2003-07-23 |
Novo Nordisk A/S |
Insulin derivatives
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
DK0828753T3
(da)
|
1995-06-02 |
2003-06-30 |
Novozymes As |
A1/Fe-behandling af en proteinopløsning efterfulgt af membranopkoncentrering
|
|
DK0840628T3
(da)
|
1995-06-02 |
2002-10-07 |
Novo Nordisk As |
Automatisk tilbagetrækning af stempelstang
|
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
|
DE69621131T2
(de)
|
1995-06-13 |
2002-11-28 |
Novozymes A/S, Bagsvaerd |
4-substituierte-phenylboronsäuren als enzymstabilisatoren
|
|
US5688251A
(en)
|
1995-09-19 |
1997-11-18 |
Becton Dickinson And Company |
Cartridge loading and priming mechanism for a pen injector
|
|
US5674204A
(en)
|
1995-09-19 |
1997-10-07 |
Becton Dickinson And Company |
Medication delivery pen cap actuated dose delivery clutch
|
|
JP3060287B2
(ja)
|
1995-10-09 |
2000-07-10 |
参天製薬株式会社 |
アパファントを主薬とする水性点眼剤
|
|
US5899879A
(en)
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
|
PL185539B1
(pl)
|
1996-02-23 |
2003-05-30 |
Novo Nordisk As |
Strzykawka z mechanizmem ustalania dawek i elektronicznym przedstawianiem parametrów
|
|
PT885014E
(pt)
|
1996-03-05 |
2003-02-28 |
Robert Gurny |
Composicoes farmaceuticas contendo polimeros orto ester tamponados
|
|
US6277098B1
(en)
|
1996-03-12 |
2001-08-21 |
Novo Nordisk A/S |
Injection device with electronic presentation of set doses
|
|
DE59609513D1
(de)
|
1996-04-02 |
2002-09-05 |
Disetronic Licensing Ag |
Injektionsgerät
|
|
CA2252620A1
(en)
|
1996-04-24 |
1997-10-30 |
Novo Nordisk A/S |
Injection needle
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
AU737664B2
(en)
|
1996-07-03 |
2001-08-30 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
WO1998001170A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Automatic needle insertion mechanism
|
|
HUP9904152A3
(en)
|
1996-07-05 |
2000-05-29 |
Novo Nordisk As |
Flexible piston rod
|
|
CA2258308A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Dose setting device
|
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
US5962407A
(en)
|
1996-07-26 |
1999-10-05 |
Kelly; Michael T. |
Loloatin derivatives and analogs
|
|
JPH10101696A
(ja)
|
1996-08-08 |
1998-04-21 |
Shinotesuto:Kk |
形質転換体にて発現される蛋白質に含まれる夾雑物質の除去方法及び精製蛋白質
|
|
PT966297E
(pt)
|
1996-08-08 |
2009-03-18 |
Amylin Pharmaceuticals Inc |
Regulação da motilidade gastrintestinal
|
|
US5843036A
(en)
|
1996-08-23 |
1998-12-01 |
Becton Dickinson And Company |
Non-dosing cartridge for an injection device
|
|
US5709662A
(en)
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
|
EP1826216A1
(en)
|
1996-08-30 |
2007-08-29 |
Novo Nordisk A/S |
Glp-1 derivatives
|
|
US6384016B1
(en)
|
1998-03-13 |
2002-05-07 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6379339B1
(en)
|
1996-09-13 |
2002-04-30 |
Nova Nordisk A/S |
Syringe
|
|
US6110149A
(en)
|
1996-09-13 |
2000-08-29 |
Novo Nordisk A/S |
Syringe
|
|
US5947934A
(en)
|
1996-09-13 |
1999-09-07 |
Novo Nordisk A/S |
Dose display for an injection syringe
|
|
JP3989966B2
(ja)
|
1996-09-13 |
2007-10-10 |
ノボ ノルディスク アクティーゼルスカブ |
注入式注射器用投薬量ディスプレイ
|
|
EP0927055B1
(en)
|
1996-09-20 |
2001-12-05 |
Novo Nordisk A/S |
Working cylinder
|
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
TW524667B
(en)
|
1996-12-05 |
2003-03-21 |
Pfizer |
Parasiticidal pyrazoles
|
|
US5954689A
(en)
|
1996-12-20 |
1999-09-21 |
Novo Nordisk A/S |
Jet injector
|
|
DK1629849T4
(en)
|
1997-01-07 |
2017-12-04 |
Amylin Pharmaceuticals Llc |
Pharmaceutical compositions comprising exedins and agonists thereof
|
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
|
KR20000070338A
(ko)
|
1997-01-20 |
2000-11-25 |
나가시마 카쭈시게, 노미야마 아키히코 |
펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
|
|
GB2321419B
(en)
|
1997-01-27 |
2001-02-07 |
Medic Aid Ltd |
Atomizer
|
|
WO1998033538A1
(en)
|
1997-02-04 |
1998-08-06 |
Novo Nordisk A/S |
A device for the administration of a liquid medicament suspension
|
|
DE29703820U1
(de)
|
1997-03-03 |
1998-07-02 |
Medico Development Investment Co., Ascona |
Injektionsgerät
|
|
US5898028A
(en)
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
|
US6277097B1
(en)
|
1997-03-25 |
2001-08-21 |
Novo Nordisk A/S |
Injection system
|
|
WO1998043658A1
(en)
|
1997-03-31 |
1998-10-08 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
|
US7101853B2
(en)
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
|
RU2111019C1
(ru)
|
1997-05-22 |
1998-05-20 |
Сергей Александрович Хворостов |
Универсальный инъектор
|
|
SK159599A3
(en)
|
1997-05-23 |
2000-11-07 |
Predrag Sikiric |
New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
|
|
US7910548B2
(en)
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
|
US6074372A
(en)
|
1997-06-09 |
2000-06-13 |
Novo Nordisk A/S |
Dose setting mechanism and an injection syringe having such a dose setting mechanism
|
|
US6003736A
(en)
|
1997-06-09 |
1999-12-21 |
Novo Nordisk A/S |
Device for controlled dispensing of a dose of a liquid contained in a cartridge
|
|
US6207684B1
(en)
|
1997-06-09 |
2001-03-27 |
Bridge Pharma, Inc. |
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
|
|
PE79099A1
(es)
|
1997-06-13 |
1999-08-24 |
Lilly Co Eli |
Formulaciones de insulina estables
|
|
US5961496A
(en)
|
1997-06-17 |
1999-10-05 |
Novo Nordisk A/S |
Syringe with tiltable nut for quick piston disengagement
|
|
US6796970B1
(en)
|
1997-06-17 |
2004-09-28 |
Novo Nordisk A/S |
Dose setting device
|
|
JP3503129B2
(ja)
|
1997-06-30 |
2004-03-02 |
荒川化学工業株式会社 |
カラーフィルタ層用剥離剤およびカラーフィルタ用ガラス基板の再生方法
|
|
WO1999002210A1
(en)
|
1997-07-11 |
1999-01-21 |
Novo Nordisk A/S |
An apparatus for the registration of the setting of a medical device
|
|
JP2003514586A
(ja)
|
1997-07-14 |
2003-04-22 |
ノボ ノルディスク アクティーゼルスカブ |
円筒状アンプル
|
|
WO1999003521A1
(en)
|
1997-07-14 |
1999-01-28 |
Novo Nordisk A/S |
Injection member
|
|
DE19730999C1
(de)
|
1997-07-18 |
1998-12-10 |
Disetronic Licensing Ag |
Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
|
|
US5957896A
(en)
|
1997-08-11 |
1999-09-28 |
Becton, Dickinson And Company |
Medication delivery pen
|
|
FR2767479B1
(fr)
|
1997-08-22 |
1999-10-22 |
Aguettant Lab |
Dispositif d'injection de medicament
|
|
AU9202398A
(en)
|
1997-09-29 |
1999-04-23 |
Becton Dickinson & Company |
Injection device and drug cartridge for preventing cross-use of the device and drug cartridge
|
|
EP2042161A1
(en)
|
1997-10-01 |
2009-04-01 |
Novadel Pharma Inc. |
Propellant-free spray composition comprising anti-emetic agent
|
|
DE69813599T2
(de)
|
1997-10-24 |
2004-04-08 |
Genentech, Inc., South San Francisco |
Reinigung von molekülen
|
|
IL135400A0
(en)
|
1997-10-24 |
2001-05-20 |
Novo Nordisk As |
Aggregates of human insulin derivatives
|
|
US6312413B1
(en)
|
1997-10-30 |
2001-11-06 |
Novo Nordisk A/S |
Cylinder ampoule
|
|
EP1049486A4
(en)
|
1997-12-05 |
2006-01-04 |
Lilly Co Eli |
GLP-1 FORMULATIONS
|
|
DE29721752U1
(de)
|
1997-12-09 |
1998-02-12 |
Siemens AG, 80333 München |
Crimpkontakt für Stecksysteme
|
|
MY120063A
(en)
|
1997-12-09 |
2005-08-30 |
Lilly Co Eli |
Stabilized teriparatide solutions
|
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
|
JPH11249087A
(ja)
|
1997-12-18 |
1999-09-17 |
Tome:Kk |
コンタクトレンズ用液剤
|
|
WO1999034764A2
(en)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
|
JP4353544B2
(ja)
|
1998-01-09 |
2009-10-28 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
アミリン作動薬ペプチド用製剤
|
|
CA2284847A1
(en)
|
1998-01-30 |
1999-08-05 |
Suntory Limited |
Process for producing peptides using a helper peptide
|
|
ES2153711T3
(es)
|
1998-01-30 |
2001-03-01 |
Novo Nordisk As |
Jeringuilla de inyeccion.
|
|
US6770288B2
(en)
|
1998-02-13 |
2004-08-03 |
Pfizer Products Inc. |
Drug delivery system
|
|
ATE366115T1
(de)
|
1998-02-13 |
2007-07-15 |
Amylin Pharmaceuticals Inc |
Inotropische und diuretische effekte von exendin und glp-1
|
|
ES2356595T3
(es)
|
1998-02-13 |
2011-04-11 |
Amylin Pharmaceuticals, Inc. |
Nuevos compuestos de actividad mixta de la amilina.
|
|
US5961495A
(en)
|
1998-02-20 |
1999-10-05 |
Becton, Dickinson And Company |
Medication delivery pen having a priming mechanism
|
|
US6221053B1
(en)
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
|
US6248095B1
(en)
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
|
EP1056774A1
(en)
|
1998-02-27 |
2000-12-06 |
Novo Nordisk A/S |
N-terminally truncated glp-1 derivatives
|
|
JP2002506792A
(ja)
|
1998-02-27 |
2002-03-05 |
ノボ ノルディスク アクティーゼルスカブ |
Ｎ末端修飾ｇｌｐ−１誘導体
|
|
DE69942306D1
(de)
|
1998-02-27 |
2010-06-10 |
Novo Nordisk As |
Abkömmlinge von glp-1 analogen
|
|
JP2002504518A
(ja)
|
1998-02-27 |
2002-02-12 |
ノボ ノルディスク アクティーゼルスカブ |
部分的に構造化されたミセルー様凝集体を形成する、２５％を超えるヘリックス−含有率を有するｇｌｐ−１誘導体
|
|
JP2003522099A
(ja)
|
1998-02-27 |
2003-07-22 |
ノボ ノルディスク アクティーゼルスカブ |
遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン
|
|
AU2612599A
(en)
|
1998-03-13 |
1999-10-11 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
|
AU3772199A
(en)
|
1998-05-01 |
1999-11-23 |
University Of Tennessee Research Corporation, The |
Flow cytometric characterization of amyloid fibrils
|
|
AU4435399A
(en)
|
1998-06-11 |
1999-12-30 |
Cerus Corporation |
Inhibiting proliferation of arterial smooth muscle cells
|
|
AU4769599A
(en)
|
1998-07-08 |
2000-02-01 |
Novo Nordisk A/S |
A medical delivery device and a cartridge assembly for use in the same
|
|
CN1317967A
(zh)
|
1998-09-17 |
2001-10-17 |
伊莱利利公司 |
蛋白质制剂
|
|
US6033376A
(en)
|
1998-09-30 |
2000-03-07 |
Allergan Sales, Inc. |
Wound shaper sleeve
|
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
|
US6605067B1
(en)
|
1998-11-20 |
2003-08-12 |
Novo Nordisk A/S |
Injection needle
|
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
|
WO2000037098A1
(en)
|
1998-12-22 |
2000-06-29 |
Eli Lilly And Company |
Shelf-stable formulation of glucagon-like peptide-1
|
|
DE29900482U1
(de)
|
1999-01-14 |
2000-08-31 |
Medico Development Investment Co., Ascona |
Injektionsgerät
|
|
DE60021166T3
(de)
|
1999-01-14 |
2019-08-22 |
Amylin Pharmaceuticals, Llc |
Neue exendin agonist formulierungen und deren verabreichung
|
|
AU3421600A
(en)
|
1999-02-14 |
2000-08-29 |
Ing. Erich Pfeiffer Gmbh |
Dispenser for flowable media
|
|
US6258062B1
(en)
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
|
US6444788B1
(en)
|
1999-03-15 |
2002-09-03 |
Novo Nordisk A/S |
Ion exchange chromatography of GLP-1, analogs and derivatives thereof
|
|
IL144989A0
(en)
|
1999-03-17 |
2002-06-30 |
Novo Nordisk As |
Method for acylating peptides and novel acylating agents
|
|
SE9901366D0
(sv)
|
1999-04-16 |
1999-04-16 |
Pharmacia & Upjohn Ab |
Injector device and method for its operation
|
|
FR2793684B1
(fr)
|
1999-05-17 |
2001-08-10 |
Ethypharm Lab Prod Ethiques |
Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
KR20020059255A
(ko)
|
1999-06-17 |
2002-07-12 |
린다 에스. 스티븐슨 |
저온 저장을 개선하기 위한 ＰＥＧ-Ｈｂ를 사용하는 연속심장 관류 보존
|
|
AU5325200A
(en)
|
1999-06-21 |
2001-01-09 |
Eli Lilly And Company |
Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes
|
|
EP1196189A2
(en)
|
1999-06-25 |
2002-04-17 |
Medtronic MiniMed, Inc. |
Multiple agent diabetes therapy
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
ES2258469T3
(es)
|
1999-08-05 |
2006-09-01 |
Becton Dickinson And Company |
Lapiz de administracion de medicacion.
|
|
TW453884B
(en)
|
1999-09-16 |
2001-09-11 |
Novo Nordisk As |
Dose setting limiter
|
|
CA2383574A1
(en)
|
1999-09-20 |
2001-03-29 |
Eli Lilly And Company |
Method for reducing the risk of cancer
|
|
US6514230B1
(en)
|
1999-10-12 |
2003-02-04 |
Novo Nordisk A/S |
Air shot mechanism for electronic injection devices
|
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
PL355378A1
(en)
|
1999-12-16 |
2004-04-19 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
|
EP1250126A2
(en)
|
2000-01-11 |
2002-10-23 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
|
AU2001220765A1
(en)
|
2000-01-24 |
2001-07-31 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
US7598222B2
(en)
|
2000-01-27 |
2009-10-06 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 compounds
|
|
EP1396499A3
(en)
|
2000-01-27 |
2004-12-29 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds
|
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
|
GB0007071D0
(en)
|
2000-03-24 |
2000-05-17 |
Sams Bernard |
One-way clutch mechanisms and injector devices
|
|
AU2001248277A1
(en)
|
2000-04-06 |
2001-10-23 |
Novo-Nordisk A/S |
Shock heat treatment of polypeptides
|
|
US6692472B2
(en)
|
2000-05-04 |
2004-02-17 |
Novo Nordisk A/S |
Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
|
|
CA2380423A1
(en)
|
2000-05-17 |
2001-11-22 |
Bionebraska, Inc. |
Peptide pharmaceutical formulations
|
|
US6716198B2
(en)
|
2000-05-18 |
2004-04-06 |
Novo Nordisk A/S |
Injection device
|
|
US6547763B2
(en)
|
2000-05-18 |
2003-04-15 |
Novo Nordisk A/S |
Dose display for injection device
|
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
|
DK1695983T3
(da)
|
2000-06-16 |
2009-05-18 |
Lilly Co Eli |
Glucagon-lignende peptid-1 analoger
|
|
US6663602B2
(en)
|
2000-06-16 |
2003-12-16 |
Novo Nordisk A/S |
Injection device
|
|
US6369419B1
(en)
|
2000-06-23 |
2002-04-09 |
International Business Machines Corporation |
Self-aligned near surface strap for high density trench DRAMS
|
|
ATE386563T1
(de)
|
2000-07-14 |
2008-03-15 |
Novo Nordisk As |
Flüssigkeitsabgabevorrichtung und verfahren zum vermindern des tröpfelns
|
|
WO2002024257A1
(en)
|
2000-09-22 |
2002-03-28 |
Novo Nordisk A/S |
A medication delivery device
|
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
|
KR20080085082A
(ko)
|
2000-12-07 |
2008-09-22 |
일라이 릴리 앤드 캄파니 |
Ｇｌｐ-1 융합 단백질
|
|
WO2002047716A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
US20020151467A1
(en)
|
2000-12-21 |
2002-10-17 |
Leung Frank K. |
Methods and compositions for oral insulin delivery
|
|
US6899699B2
(en)
|
2001-01-05 |
2005-05-31 |
Novo Nordisk A/S |
Automatic injection device with reset feature
|
|
GB2371227A
(en)
|
2001-01-10 |
2002-07-24 |
Grandis Biotech Gmbh |
Crystallisation - resistant aqueous growth hormone formulations
|
|
EP1361908B1
(en)
|
2001-02-14 |
2007-12-19 |
Novo Nordisk A/S |
Electronically controlled injection or infusion device
|
|
CA2436399A1
(en)
|
2001-02-16 |
2002-08-29 |
Conjuchem Inc. |
Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
|
|
AU2002235731A1
(en)
|
2001-03-07 |
2002-09-19 |
Novo Nordisk A/S |
Combined use of derivatives of glp-1 analogs and ppar ligands
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
EP1776975B1
(en)
|
2001-05-16 |
2011-06-22 |
Eli Lilly & Company |
Medication injector apparatus with drive assembly that facilitates reset
|
|
US20040156835A1
(en)
|
2001-05-30 |
2004-08-12 |
Taiji Imoto |
Protein preparation
|
|
GB0113881D0
(en)
|
2001-06-07 |
2001-08-01 |
Innovate Biomed Ltd |
Foil cutting system
|
|
EP1412384B1
(en)
|
2001-06-28 |
2007-12-26 |
Novo Nordisk A/S |
Stable formulation of modified glp-1
|
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
|
DE10163326A1
(de)
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
|
CN1635900A
(zh)
|
2001-08-28 |
2005-07-06 |
伊莱利利公司 |
Glp－1和基础胰岛素的预混合物
|
|
US6676641B2
(en)
|
2001-09-05 |
2004-01-13 |
Futura Medical Technologies, Inc. |
Retractable hypodermic syringe
|
|
HUP0700151A2
(en)
|
2001-10-18 |
2007-05-29 |
Bristol Myers Squibb Co |
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
|
|
CA2463803A1
(en)
|
2001-10-19 |
2003-05-01 |
Eli Lilly And Company |
Biphasic mixtures of glp-1 and insulin
|
|
BR0307727A
(pt)
|
2002-02-20 |
2005-01-25 |
Lilly Co Eli |
Fomulação
|
|
US6941948B2
(en)
|
2002-03-07 |
2005-09-13 |
Vectura Drug Delivery |
Medicament storage and delivery devices
|
|
CN1652813A
(zh)
|
2002-03-15 |
2005-08-10 |
纳蒂芒公司 |
包含甘露糖结合凝集素的药用组合物
|
|
WO2003084563A1
(en)
|
2002-04-04 |
2003-10-16 |
Novo Nordisk A/S |
Glp-1 agonist and cardiovascular complications
|
|
MXPA05000413A
(es)
|
2002-07-09 |
2005-07-22 |
Sandoz Ag |
Formulaciones liquidas con una alta concentracion de hormona de crecimiento humana (hgh) que comprenden 1,2-propilenglicol.
|
|
EP1521607A1
(en)
|
2002-07-10 |
2005-04-13 |
Novo Nordisk A/S |
An injection device with a dose setting limiter
|
|
US6945961B2
(en)
|
2002-07-10 |
2005-09-20 |
Novo Nordisk A/S |
Injection device
|
|
EP1391794A1
(en)
|
2002-07-23 |
2004-02-25 |
Novo Nordisk A/S |
Device with time indicating means
|
|
ATE331542T1
(de)
|
2002-08-29 |
2006-07-15 |
Novo Nordisk As |
Injektionsvorrichtung mit frontladung
|
|
CA2500195C
(en)
|
2002-09-24 |
2009-07-21 |
Shl Medical Ab |
Injecting device
|
|
ES2308029T3
(es)
|
2002-09-25 |
2008-12-01 |
Novo Nordisk A/S |
Proceso de purificacion que comprende una microfiltracion a temperaturas elevadas.
|
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
|
AU2003278929A1
(en)
|
2002-10-18 |
2004-05-13 |
Amylin Pharmaceuticals, Inc. |
Treatment of pancreatitis with amylin
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
AU2003297356A1
(en)
|
2002-12-17 |
2004-07-14 |
Amylin Pharmaceuticals, Inc. |
Prevention and treatment of cardiac arrhythmias
|
|
WO2004066939A2
(en)
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
GB0304822D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0304823D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0304824D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0306642D0
(en)
|
2003-03-22 |
2003-04-30 |
Dca Design Int Ltd |
Improvements in and relating to an injector for a medical product
|
|
GB0308267D0
(en)
|
2003-04-10 |
2003-05-14 |
Dca Design Int Ltd |
Improvements in and relating to a pen-type injector
|
|
WO2004089985A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Stable pharmaceutical compositions
|
|
WO2005000222A2
(en)
|
2003-05-30 |
2005-01-06 |
Amylin Pharmaceuticals, Inc. |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
WO2004105781A2
(en)
|
2003-06-03 |
2004-12-09 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
|
CN102940879B
(zh)
*
|
2003-06-03 |
2017-06-06 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
|
CN1812807A
(zh)
*
|
2003-06-03 |
2006-08-02 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
|
SI1656170T1
(sl)
|
2003-08-12 |
2019-05-31 |
Eli Lilly And Company |
Oprema za izdajanje zdravil s trojnim vijačnim navojem za mehanski pospešek
|
|
WO2005021026A2
(en)
|
2003-08-29 |
2005-03-10 |
Amylin Pharmaceuticals, Inc. |
Methods for treating or ameliorating ghrelin-associated diseases and disorders
|
|
BR122019021416A2
(sr)
|
2003-09-19 |
2019-12-21 |
|
|
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
|
WO2005044854A2
(en)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Antagonist anti-cd40 monoclonal antibodies and methods for their use
|
|
BR122018071808B8
(pt)
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
|
EP1684793B1
(en)
|
2003-11-13 |
2011-09-21 |
Novo Nordisk A/S |
Pharmaceutical composition comprising an insulinotropic glp-1(7-37) analogue, asp(b28)-insulin, and a surfactant
|
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
|
CN113304250A
(zh)
*
|
2003-11-20 |
2021-08-27 |
诺和诺德股份有限公司 |
对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
|
|
EP1694278A4
(en)
|
2003-12-16 |
2009-08-12 |
Ipsen Pharma |
GLP-1 PHARMACEUTICAL COMPOSITIONS
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
|
JP2008500281A
(ja)
|
2004-02-11 |
2008-01-10 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
アミリンファミリーペプチドおよびそれらを作成し使用するための方法
|
|
EP1765406A4
(en)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
|
|
US7448385B2
(en)
|
2004-06-07 |
2008-11-11 |
Purepharm Inc. |
Nasal adaptation of an oral inhaler device
|
|
WO2005120492A1
(en)
|
2004-06-11 |
2005-12-22 |
Novo Nordisk A/S |
Counteracting drug-induced obesity using glp-1 agonists
|
|
US20090042781A1
(en)
|
2004-06-28 |
2009-02-12 |
Novo Nordisk A/S |
Methods for Treating Diabetes
|
|
WO2006025882A2
(en)
|
2004-08-25 |
2006-03-09 |
The Uab Research Foundation |
Absorption enhancers for drug administration
|
|
ATE427759T1
(de)
|
2004-11-01 |
2009-04-15 |
Amylin Pharmaceuticals Inc |
Behandlung von fettsucht und verbundenen erkrankungen
|
|
JP5248113B2
(ja)
|
2004-11-12 |
2013-07-31 |
ノヴォ ノルディスク アー／エス |
ペプチドの安定な処方
|
|
US20080125361A1
(en)
|
2004-11-12 |
2008-05-29 |
Novo Nordisk A/S |
Stable Formulations Of Peptides
|
|
KR20130030305A
(ko)
|
2004-11-16 |
2013-03-26 |
엘란 파마 인터내셔널 리미티드 |
주사가능한 나노입자형 올란자핀 제형
|
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
|
DK1843809T3
(en)
|
2005-01-21 |
2017-07-31 |
Novo Nordisk As |
AUTOMATIC INJECTION DEVICE WITH A TOP TRANSMISSION MECHANISM
|
|
NZ561137A
(en)
|
2005-03-08 |
2011-09-30 |
Pharmacia & Upjohn Co Llc |
Stable anti-CTLA-4 antibody compositions with chelating agents
|
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
|
TWI372629B
(en)
*
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2007014051A2
(en)
|
2005-07-22 |
2007-02-01 |
Amylin Pharmaceuticals, Inc. |
Use of amylin and amylin agonists as cardioprotective or myoprotective agents
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
JP2009519962A
(ja)
|
2005-12-19 |
2009-05-21 |
コメンティス，インコーポレーテッド |
眼投与用局所メカミルアミン製剤およびその使用
|
|
ES2572736T3
(es)
|
2005-12-29 |
2016-06-02 |
Boehringer Ingelheim Vetmedica, Inc. |
Uso de una composición inmunógena para atenuar síntomas clínicos en cerdos
|
|
MX2008013168A
(es)
|
2006-04-13 |
2008-10-27 |
Sod Conseils Rech Applic |
Composiciones faramaceuticas del peptido 1 similar al glucagon humano, exendina-4 y análogos de los mismos.
|
|
KR20090039787A
(ko)
|
2006-07-18 |
2009-04-22 |
센토코 인코포레이티드 |
인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
UY30820A1
(es)
|
2006-12-21 |
2008-07-03 |
Centocor Inc |
Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
|
|
GB0704846D0
(en)
|
2007-03-13 |
2007-04-18 |
Futura Medical Dev Ltd |
Topical pharmaceutical formulation
|
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
|
ES2532116T3
(es)
|
2007-09-05 |
2015-03-24 |
Novo Nordisk A/S |
Péptidos derivados con A-B-C-D y sus usos terapéuticos
|
|
KR20100056515A
(ko)
|
2007-09-11 |
2010-05-27 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 펩티드의 용도
|
|
WO2009051992A1
(en)
|
2007-10-19 |
2009-04-23 |
Bausch & Lomb Incorporated |
Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases
|
|
US20100323955A1
(en)
|
2007-11-14 |
2010-12-23 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity and obesity related diseases and disorders
|
|
WO2009075859A2
(en)
|
2007-12-11 |
2009-06-18 |
Conjuchem Biotechnologies Inc. |
Formulation of insulinotropic peptide conjugates
|
|
JP5703226B2
(ja)
|
2008-10-21 |
2015-04-15 |
ノヴォ ノルディスク アー／エス |
アミリン誘導体
|
|
WO2010107874A2
(en)
|
2009-03-17 |
2010-09-23 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition using amylin agonists
|
|
US20120136298A1
(en)
|
2009-06-04 |
2012-05-31 |
Novo Nordisk Healthcare A/G |
Mixing device with piston coupling arrangement
|
|
AU2010277560B2
(en)
|
2009-07-31 |
2014-12-11 |
Sanofi-Aventis Deutschland Gmbh |
Long acting insulin composition
|
|
JP5738291B2
(ja)
|
2009-07-31 |
2015-06-24 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
インスリンリンカー複合体を含むプロドラッグ
|
|
WO2011050008A2
(en)
|
2009-10-19 |
2011-04-28 |
Amylin Pharmaceuticals, Inc. |
Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
|
|
CN102652015B
(zh)
|
2009-12-10 |
2016-08-03 |
默克专利有限公司 |
包含寡肽、优选西仑吉肽的药物组合物
|
|
CN104311657B
(zh)
|
2009-12-16 |
2020-12-08 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
|
US20130012432A1
(en)
|
2010-02-26 |
2013-01-10 |
Novo Nordisk A/S |
Peptides for Treatment of Obesity
|
|
WO2011109784A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Formulation of insulinotropic peptide conjugates
|
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
|
JP6054861B2
(ja)
|
2010-03-26 |
2016-12-27 |
ノヴォ ノルディスク アー／エス |
新規のグルカゴン類似体
|
|
KR20130101005A
(ko)
|
2010-07-28 |
2013-09-12 |
아밀린 파마슈티칼스, 엘엘씨. |
안정화된 영역을 갖는 glp-1 수용체 효능제 화합물
|
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
|
WO2012062803A1
(en)
|
2010-11-09 |
2012-05-18 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
|
US20140045754A1
(en)
|
2011-01-19 |
2014-02-13 |
Joern Drustrup |
Glp-1 compositions
|
|
CA2826506C
(en)
|
2011-02-04 |
2017-07-25 |
Biocopea Limited |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
KR101972836B1
(ko)
|
2011-04-12 |
2019-04-29 |
노보 노르디스크 에이/에스 |
이중 아실화된 ｇｌｐ-1 유도체
|
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
|
KR102066987B1
(ko)
|
2011-06-10 |
2020-01-16 |
노보 노르디스크 에이/에스 |
폴리펩티드
|
|
WO2013009539A1
(en)
|
2011-07-08 |
2013-01-17 |
Amylin Pharmaceuticals, Inc. |
Engineered polypeptides having enhanced duration of action and reduced immunogenicity
|
|
US9132170B2
(en)
|
2011-07-29 |
2015-09-15 |
Case Western Reserve University |
Compositions and methods for treating cognitive deficits
|
|
US9758560B2
(en)
|
2011-09-06 |
2017-09-12 |
Novo Nordisk A/S |
GLP-1 derivatives
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
CN104244981A
(zh)
|
2011-12-09 |
2014-12-24 |
诺和诺德A/S |
Glp-1激动剂
|
|
CN104185639B
(zh)
|
2012-03-01 |
2018-06-19 |
诺和诺德股份有限公司 |
Glp-1前体药物
|
|
CN102579350B
(zh)
|
2012-03-02 |
2013-04-24 |
海南灵康制药有限公司 |
右旋布洛芬脂质体固体制剂
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
CA2868688A1
(en)
|
2012-04-03 |
2013-10-10 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
|
WO2013156594A1
(en)
|
2012-04-19 |
2013-10-24 |
Novo Nordisk A/S |
Human amylin analogues
|
|
CN104411322B
(zh)
|
2012-05-08 |
2017-05-24 |
诺和诺德股份有限公司 |
双酰化glp‑1衍生物
|
|
CN104519902B
(zh)
|
2012-05-08 |
2017-10-27 |
诺和诺德股份有限公司 |
双酰化glp‑1衍生物
|
|
US20150174209A1
(en)
|
2012-05-25 |
2015-06-25 |
Amylin Pharmaceuticals. Llc |
Insulin-pramlintide compositions and methods for making and using them
|
|
KR101720885B1
(ko)
|
2012-06-19 |
2017-03-28 |
데비오팜 인터네셔날 에스 에이 |
(e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
|
|
EP3689365A1
(en)
|
2012-07-01 |
2020-08-05 |
Novo Nordisk A/S |
Use of long-acting glp-1 peptides
|
|
US20150273069A1
(en)
*
|
2012-10-17 |
2015-10-01 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
|
AU2014228460B2
(en)
|
2013-03-15 |
2018-11-01 |
Rhythm Pharmaceuticals, Inc. |
Pharmaceutical compositions
|
|
PT2991671T
(pt)
|
2013-05-02 |
2018-11-05 |
Novo Nordisk As |
Dosagem oral de compostos de glp-1
|
|
CA2911818A1
(en)
|
2013-05-10 |
2014-11-13 |
Nimbus Apollo, Inc. |
Acc inhibitors and uses thereof
|
|
WO2014202780A1
(en)
|
2013-06-21 |
2014-12-24 |
Novo Nordisk A/S |
Novel uses of glp-1 receptor agonists in patients treated with insulin and/or suffering from type 1 diabetes
|
|
KR20160029079A
(ko)
|
2013-07-04 |
2016-03-14 |
노보 노르디스크 에이/에스 |
Glp-1 유사 펩티드의 유도체 및 그것의 사용
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
CN103405753B
(zh)
*
|
2013-08-13 |
2016-05-11 |
上海仁会生物制药股份有限公司 |
稳定的促胰岛素分泌肽水针药物组合物
|
|
EP3129041B1
(en)
|
2014-04-07 |
2019-06-12 |
Novo Nordisk A/S |
Double-acylated glp-1 compounds
|
|
CA2952969A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Llc |
Pharmaceutical compositions
|
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
|
WO2016038521A1
(en)
|
2014-09-08 |
2016-03-17 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of liraglutide
|
|
ES2739289T3
(es)
*
|
2014-11-27 |
2020-01-30 |
Novo Nordisk As |
Derivados de GLP-1 y sus usos
|
|
CN105777872B
(zh)
*
|
2014-12-16 |
2019-06-07 |
深圳翰宇药业股份有限公司 |
一种萨摩鲁肽的纯化方法
|
|
CN107249620B
(zh)
|
2015-05-13 |
2018-06-26 |
杭州九源基因工程有限公司 |
一种包含glp-1类似物的药物制剂及其制备方法
|
|
TW201706291A
(zh)
|
2015-07-10 |
2017-02-16 |
賽諾菲公司 |
作為選擇性肽雙重ｇｌｐ－１／升糖素受體促效劑之新毒蜥外泌肽（ｅｘｅｎｄｉｎ－４）衍生物
|
|
WO2017149070A1
(en)
|
2016-03-03 |
2017-09-08 |
Novo Nordisk A/S |
Glp-1 derivatives and uses thereof
|
|
AU2017256774B2
(en)
|
2016-04-28 |
2024-07-11 |
Novo Nordisk A/S |
Semaglutide in cardiovascular conditions
|
|
US20190374613A1
(en)
|
2016-11-22 |
2019-12-12 |
Biocon Research Limited |
Pharmaceutical compositions of glp-1 analogues
|
|
GB201621987D0
(en)
|
2016-12-22 |
2017-02-08 |
Archer Virgil L See Archer Sheri A Arecor Ltd |
Novel composition
|
|
KR20190124704A
(ko)
|
2017-01-24 |
2019-11-05 |
마크레젠, 인크. |
아포지질단백질 모방체를 이용하는, 나이 관련 황반 변성 및 기타 안질환의 치료
|
|
KR102665710B1
(ko)
|
2017-08-24 |
2024-05-14 |
노보 노르디스크 에이/에스 |
Glp-1 조성물 및 그 용도
|
|
AR114162A1
(es)
|
2017-12-21 |
2020-07-29 |
Sanofi Sa |
Composición farmacéutica líquida
|
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
|
CN112566652A
(zh)
|
2018-06-25 |
2021-03-26 |
Jcr制药股份有限公司 |
含有蛋白的水性液体制剂
|
|
IL294521A
(en)
|
2020-02-18 |
2022-09-01 |
Novo Nordisk As |
glp-1 compounds and their uses
|